We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.40 | 0.20% | 1,708.60 | 1,708.60 | 1,708.80 | 1,713.00 | 1,699.40 | 1,701.60 | 11,522,668 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.27 | 70.34B |
TIDMGSK
RNS Number : 6952T
GlaxoSmithKline PLC
16 October 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ====================================================================== a) Name Mr D S Redfern === ======================== ============================================ b) Position/status Chief Strategy Officer === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 12 October 2017, on shares held within an ISA. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP15.1950 23 ------------ ---------- === ======================== ============================================ d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================ e) Date of the transaction 2017-10-13 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================ 1. Details of PDMR/person closely associated with them ('PCA') === ====================================================================== a) Name Mrs V A Whyte === ======================== ============================================ b) Position/status Company Secretary === ======================== ============================================ c) Initial notification/ Initial notification amendment === ======================== ============================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ====================================================================== a) Name GlaxoSmithKline plc === ======================== ============================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ============================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ====================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ============================================ b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 12 October 2017, on shares held within an ISA. === ======================== ============================================ c) Price(s) and Price(s) Volume(s) volume(s) ------------ ---------- GBP15.1950 19 ------------ ---------- === ======================== ============================================ d) Aggregated information n/a (single transaction) Aggregated volume Price === ======================== ============================================ e) Date of the transaction 2017-10-13 === ======================== ============================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBQLFFDBFBFBF
(END) Dow Jones Newswires
October 16, 2017 06:02 ET (10:02 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions